Home›People›David Liederbach
David Liederbach

David Liederbach

President, Quiver Bioscience

Executive
Updated Nov 7, 2026·Latest SEC filing Oct 21, 2026·Suggest an edit

About David Liederbach

Dave Liederbach is president of Quiver Bioscience, a company focused on drug discovery. He sits on the leadership team with founder and chief executive officer Graham Dempsey.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name David Liederbach in the role, so the role may have started earlier or lasted longer.

Quiver Holdings Inc. Current
President
2026 – Present · Cambridge, MA
Quiver Bioscience measures how human neurons function at scale and uses AI to find and test drugs for neurological disease.

Key Colleagues at Startups

The people David Liederbach works with at each company, as listed on that company's latest Form D.

Quiver Holdings Inc. · Form D, Oct 21, 2026
Graham Dempsey
Graham Dempsey
Founder, Chief Executive Officer
David Margulies
David Margulies
Founder, Board Member
Paul Roma
Paul Roma
Founder, Chairman of the Board
Jonathan Fleming
Jonathan Fleming
Board of Directors
Janet Foutty
Janet Foutty
Board of Directors
Paul Black
Paul Black
Board of Directors

Sources

  1. SECQuiver Holdings Inc. Form D, filed Oct 21, 2026